ASSETMARK, INC – Regeneron Pharmaceuticals, Inc. Transaction History
ASSETMARK, INC portfolio value:
$46.31M
portfolio value
ASSETMARK, INC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.96% | -653 shares | 6.18M | $688.87 | 67.23K |
| Q2 2022 | share | Decrease | -6.84% | -4.98K shares | -10.76M | $591.13 | 67.88K |
| Q1 2022 | share | Increase | +17.60% | 10.90K shares | 11.76M | $698.42 | 72.86K |
| Q4 2021 | share | Increase | +3.39% | 2.03K shares | 2.86M | $642.51 | 61.96K |
| Q3 2021 | share | Decrease | -1.66% | -1.01K shares | 2.23M | $605.18 | 59.93K |
| Q2 2021 | share | Decrease | -3.47% | -2.19K shares | 4.16M | $558.54 | 60.94K |
| Q1 2021 | share | Increase | +9.53% | 5.49K shares | 2.02M | $473.14 | 63.13K |
| Q4 2020 | share | Increase | +80.18% | 25.65K shares | 9.93M | $483.11 | 57.64K |
| Q3 2020 | share | Increase | +2689.01% | 30.84K shares | 17.19M | $559.78 | 31.99K |
| Q2 2020 | share | Increase | +2506.82% | 1.10K shares | 694K | $623.65 | 1.14K |
| Q1 2020 | share | Increase | 0.00% | 44 shares | 21K | $488.29 | 44 |
| Q4 2019 | share | Decrease | -100.00% | -3.88K shares | -1.07M | $375.48 | 0 |
| Q3 2019 | share | Increase | +20357.89% | 3.86K shares | 1.07M | $277.4 | 3.88K |
| Q2 2019 | share | Decrease | -90.91% | -190 shares | -80K | $313 | 19 |
| Q1 2019 | share | Decrease | -21.43% | -57 shares | -13K | $410.62 | 209 |
| Q4 2018 | share | Increase | +14.16% | 33 shares | 5K | $373.5 | 266 |
| Q3 2018 | share | Increase | +198.72% | 155 shares | 67K | $404.04 | 233 |
| Q2 2018 | share | Increase | +23.81% | 15 shares | 5K | $344.99 | 78 |
| Q1 2018 | share | Decrease | -30.00% | -27 shares | -12K | $344.36 | 63 |
| Q4 2017 | share | Increase | +47.54% | 29 shares | 7K | $375.96 | 90 |
| Q3 2017 | share | Increase | +10.91% | 6 shares | 0 | $447.12 | 61 |
| Q2 2017 | share | Decrease | -6.78% | -4 shares | 4K | $491.14 | 55 |
| Q1 2017 | share | Increase | +25.53% | 12 shares | 6K | $387.51 | 59 |
| Q4 2016 | share | Increase | +6.82% | 3 shares | -1K | $367.09 | 47 |
| Q3 2016 | share | Increase | +25.71% | 9 shares | 6K | $402.02 | 44 |
| Q2 2016 | share | Decrease | -42.62% | -26 shares | -10K | $349.23 | 35 |
| Q1 2016 | share | Increase | +177.27% | 39 shares | 10K | $360.44 | 61 |